Merck Will Buy Rights to Neuromed's Experimental Pain Drugs (Vioxx medication)

Merck Will Buy Rights to Neuromed's Experimental Pain Drugs
March 20 (Bloomberg) -- Merck & Co. said it has agreed to buy rights to pain drugs being developed by closely held Neuromed Pharmaceuticals Ltd. for as much as $475 million.
Source: www.bloomberg.com